Liat Alon-Shargian

Tel Aviv, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis.

Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis.

Journal: Bone marrow transplantation

Published: July 21, 2021

Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients - a matched control multicenter cohort study.

Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients - a matched control multicenter cohort study.

Journal: Haematologica

Published: January 08, 2021

Diarrheal Morbidity During Hematopoietic Cell Transplantation: The Diagnostic Yield of Stool Cultures.

Diarrheal Morbidity During Hematopoietic Cell Transplantation: The Diagnostic Yield of Stool Cultures.

Journal: Infectious diseases and therapy

Published: December 27, 2020

Venetoclax and donor lymphocyte infusion for early relapsed acute myeloid leukemia after allogeneic hematopoietic cell transplantation. A retrospective multicenter trial.

Venetoclax and donor lymphocyte infusion for early relapsed acute myeloid leukemia after allogeneic hematopoietic cell transplantation. A retrospective multicenter trial.

Journal: Annals of hematology

Published: October 18, 2020

Obinutuzumab-related adverse events: A systematic review and meta-analysis.

Obinutuzumab-related adverse events: A systematic review and meta-analysis.

Journal: Hematological oncology

Published: October 07, 2020

Consolidation Treatment for Primary Central Nervous System Lymphoma: Which Modality for Whom?

Consolidation Treatment for Primary Central Nervous System Lymphoma: Which Modality for Whom?

Journal: Acta haematologica

Published: June 19, 2020

Sequential treatment with FLAG-IDA/treosulfan conditioning regimen for patients with active acute myeloid leukemia.

Sequential treatment with FLAG-IDA/treosulfan conditioning regimen for patients with active acute myeloid leukemia.

Journal: Annals of hematology

Published: May 06, 2020

Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled study.

Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled study.

Journal: Blood advances

Published: April 10, 2020

Risk factors for mortality due to Acinetobacter baumannii bacteremia in patients with hematological malignancies - a retrospective study.

Risk factors for mortality due to Acinetobacter baumannii bacteremia in patients with hematological malignancies - a retrospective study.

Journal: Leukemia & lymphoma

Published: April 25, 2019

Reporting infections in clinical trials of patients with haematological malignancies.

Reporting infections in clinical trials of patients with haematological malignancies.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: March 07, 2019

Human herpes virus 6 reactivation following autologous hematopoietic cell transplantation - a single-center experience.

Human herpes virus 6 reactivation following autologous hematopoietic cell transplantation - a single-center experience.

Journal: Leukemia & lymphoma

Published: February 19, 2019

Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.

Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.

Journal: Acta haematologica

Published: August 09, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026